Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of 7.93 billion as of April 28, 2025. Its market cap has decreased by -28.32% in one year.

Market Cap

7.93B

Enterprise Value

7.50B

Revenue

1.88B

Ranking

n/a

PE Ratio

29.10

Stock Price

106.69

Market Cap Chart

Since May 23, 1996, Neurocrine Biosciences's market cap has increased from 136.97M to 7.93B, an increase of 5,692.29%. That is a compound annual growth rate of 15.06%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	7.93B	-28.13%
Dec 31, 2024	11.04B	8.62%
Dec 29, 2023	10.16B	6.65%
Dec 30, 2022	9.53B	59.70%
Dec 31, 2021	5.97B	-9.03%
Dec 31, 2020	6.56B	-12.24%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	161.27B
GSK plc	56.28B
Haleon	34.06B
Smith & Nephew	8.68B
ConvaTec Group	5.25B
Hikma Pharmaceuticals	4.19B
HUTCHMED (China)	1.95B
Oxford Nanopore Technologies	1.14B

Market Cap Rankings